Gluz, Oleg, Kolberg-Liedtke, Cornelia, Marme, Frederik and Thill, Marc (2020). Use of Taxanes in Metastatic HER2-negative Breast Cancer - a Status Report. Geburtshilfe Frauenheilkd., 80 (4). S. 399 - 410. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804

Full text not available from this repository.

Abstract

The most important goal of treatment of patients with metastatic breast cancer is maintenance or even improvement of quality of life. In this setting, chemotherapy should be used with as much restraint as possible. If palliative chemotherapy is indicated, the taxane drug class is an established treatment option. The updated guidelines of the Gynaecological Oncology Working Group (AGO), Breast Committee, of the German Society for Gynaecology and Obstetrics (DGGG) and the German Cancer Society e.V. (DKG) provide recommendations with the greatest possible evidence on which of the licensed taxanes can be used in which treatment situation in the metastatic setting.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Gluz, OlegUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kolberg-Liedtke, CorneliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Marme, FrederikUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thill, MarcUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-338471
DOI: 10.1055/a-1126-4247
Journal or Publication Title: Geburtshilfe Frauenheilkd.
Volume: 80
Number: 4
Page Range: S. 399 - 410
Date: 2020
Publisher: GEORG THIEME VERLAG KG
Place of Publication: STUTTGART
ISSN: 1438-8804
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
PHASE-III TRIAL; SOLVENT-BASED PACLITAXEL; INTERNATIONAL CONSENSUS GUIDELINES; WEEKLY NAB-PACLITAXEL; 1ST-LINE TREATMENT; FINAL ANALYSIS; FREE SURVIVAL; DOCETAXEL; CHEMOTHERAPY; COMBINATIONMultiple languages
Obstetrics & GynecologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/33847

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item